4.6 Article

Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke

Mira Katan et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)

Article Clinical Neurology

Posterior versus anterior circulation strokes: comparison of clinical, radiological and outcome characteristics

Gian Marco De Marchis et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Article Clinical Neurology

Copeptin: A Novel, Independent Prognostic Marker in Patients with Ischemic Stroke

Mira Katan et al.

ANNALS OF NEUROLOGY (2009)

Article Cardiac & Cardiovascular Systems

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

Mark A. Hlatky et al.

CIRCULATION (2009)

Article Clinical Neurology

Blood Markers for the Prognosis of Ischemic Stroke A Systematic Review

William Whiteley et al.

STROKE (2009)

Article Mathematical & Computational Biology

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

Michael J. Pencina et al.

STATISTICS IN MEDICINE (2008)

Article Medical Laboratory Technology

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

NG Morgenthaler et al.

CLINICAL CHEMISTRY (2006)

Article Medicine, General & Internal

Is this patient having a stroke?

LB Goldstein et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Clinical Neurology

Charlson Index comorbidity adjustment for ischemic stroke outcome studies

LB Goldstein et al.

STROKE (2004)